Related Experiment Video
Updated: Feb 27, 2026
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
[Mycoplasma pneumoniae: update and new challenges]
1Biologiste adjoint, Service des maladies infectieuses, Institut central des Hôpitaux, Hôpital du Valais, Avenue du Grand-Champsec 86, 1950 Sion.
Abstract:
Mycoplasma pneumoniae is a frequent cause of community acquired pneumonia, especially in children. Discovered by Eaton in the 1940s, it has long been considered as a virus, in part because of its difficult growth in cultures. M. pneumoniae can cause many complications, some of which are severe such as dermatological lesions or affections of the central nervous system. The laboratory diagnosis of M. pneumoniae is difficult, notably because of the fastidious growth conditions, the persistence of IgM antibody after acute infection and the debated existence of asymptomatic carriers. In recent years, the spread of mutants resistant to macrolides caused an additional challenge linked to this pathogen.
Insights
Mycoplasma pneumoniae causes community-acquired pneumonia and complications. Diagnosis is challenging due to difficult culture, persistent antibodies, and emerging macrolide resistance in this common childhood pathogen.
Area of Science:
- Infectious Diseases
- Microbiology
- Pediatrics
Background:
- Mycoplasma pneumoniae is a significant cause of community-acquired pneumonia, particularly in children.
- Historically misclassified as a virus due to cultivation difficulties.
- Associated with diverse and severe complications, including neurological and dermatological issues.
Purpose of the Study:
- To highlight the diagnostic challenges associated with Mycoplasma pneumoniae.
- To underscore the impact of macrolide-resistant strains.
- To provide an overview of the pathogen's clinical significance.
Main Methods:
- Review of Mycoplasma pneumoniae characteristics and clinical impact.
- Discussion of diagnostic limitations: culture, serology, and carrier state.
- Analysis of emerging macrolide resistance.
Main Results:
- Laboratory diagnosis is complicated by fastidious growth, persistent IgM, and uncertain asymptomatic carriage.
- Macrolide-resistant Mycoplasma pneumoniae strains present a growing clinical challenge.
- The pathogen causes significant morbidity, including severe complications.
Conclusions:
- Accurate and timely diagnosis of Mycoplasma pneumoniae remains difficult.
- Macrolide resistance necessitates careful treatment strategies.
- Further research is needed to address diagnostic and therapeutic challenges.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation